Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Gains from Sales and Divestitures: 2018

Historic Gains from Sales and Divestitures for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Jun 2018 value amounting to $107,830.

  • EyePoint Pharmaceuticals' Gains from Sales and Divestitures was N/A to $107,830 in Q2 2018 from the same period last year, while for Jun 2018 it was $107,830, marking a year-over-year change of. This contributed to the annual value of $107,830 for FY2018, which is N/A change from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Gains from Sales and Divestitures of $107,830 as of FY2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Gains from Sales and Divestitures ranged from a high of $107,830 in FY2018 and a low of $107,830 during FY2018.
  • For the 1-year period, EyePoint Pharmaceuticals' Gains from Sales and Divestitures averaged around $107,830, with its median value being $107,830 (2018).